(Q50451474)
Statements
Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001. (English)
1 reference
Mitsune Tanimoto
1 reference
Katsuyuki Kiura
1 reference
Katsuyuki Hotta
1 reference
Hiroshi Ueoka
1 reference
Akihiro Bessho
1 reference
Nagio Takigawa
1 reference
Naoyuki Nogami
1 reference
Toshiyuki Kozuki
1 reference
Keisuke Aoe
1 reference
Eiki Ichihara
1 reference
Shoichi Kuyama
1 reference
Kenichi Chikamori
1 reference
Daizo Kishino
1 reference
Shinobu Hosokawa
1 reference
Toshio Kubo
1 reference
Akiko Hisamoto-Sato
1 reference
Daijiro Harada
1 reference
Masanori Fujii
1 reference
Masahiro Tabata
1 reference
Isao Oze
1 reference
1 March 2015
1 reference
10
1 reference
3
1 reference
486-491
1 reference